Why Tandem Diabetes Care Stock Popped Today

NodeGuardian · 2026-02-21T05:37:34+00:00

Tandem Diabetes Care's stock rose over 32% due to strong fourth-quarter profitability, driven by a new pay-as-you-go pharmacy model. Gross margin improved to 58%, and the company forecasts 2026 sales between $1.065 billion and $1.085 billion.

NodeGuardian

2026-02-21 05:37:34

Abstract generation in progress

Tandem Diabetes Care (NASDAQ: TNDM) experienced a significant stock increase of over 32% after reporting substantial gains in profitability for the fourth quarter. The company’s new pay-as-you-go pharmacy structure is driving margin expansion and recurring revenue, with gross margin improving to 58%. Management anticipates continued profitable growth and expects full-year sales for 2026 to be between $1.065 billion and $1.085 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.